HBR on mobile phones transforming healthcare

Categories: Latest News.

David Aylward, executive director¬†of the mHealth Alliance, writes in the Harvard Business Review’s ‘Innovations in Health Care’ blog, focuses on the paradox of mHealth; it may be the future, but it’s supported by charity or loses money; it can reach millions but isn’t proven to be scalable.¬†‘We don’t understand the business models that will support real public private partnerships in the deployment and sustainability of mHealth systems.’ Sproxil is mentioned as a model in combining private interest–pharmaceutical sales–with public interest (the drug is genuine). Article.